Effects of interrupted immunomodulant therapy on the neurological state of multiple sclerosis patients von Bencsik, Krisztina, Fricska-Nagy, Zsanett, Csépány, Tünde, Mátyás, Klotild, Dobos, Enikő, Rózsa, Csilla, Semjén, Judit, Rajda, Cecília, Füvesi, Judit, Török, Margit, Vécsei, László

Volltext

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-contr... von Segal, Benjamin M, MD, Constantinescu, Cris S, MD, Raychaudhuri, Aparna, PhD, Kim, Lilianne, PhD, Fidelus-Gort, Rosanne, PhD, Kasper, Lloyd H, MD

Volltext

A Double‐Blind, Randomized, Placebo and Active‐Controlled Study of Nebicapone for the Treatment of Motor Fluctuations in Parkinson's Disease von Ferreira, Joaquim J., Rascol, Olivier, Poewe, Werner, Sampaio, Cristina, Rocha, José‐Francisco, Nunes, Teresa, Almeida, Luis, Soares‐da‐Silva, Patrício

Volltext